Prophylactic Mastectomy for BRCA1/2 Carriers: Progress and More Questions
Authors:
- 15 March 2004
- journal article
- editorial
- Published by American Society of Clinical Oncology (ASCO) in Journal of Clinical Oncology
- Vol. 22 (6) , 981-983
Abstract
No abstract availableThis publication has 15 references indexed in Scilit:
- Bilateral Prophylactic Mastectomy Reduces Breast Cancer Risk in BRCA1 and BRCA2 Mutation Carriers: The PROSE Study GroupJournal of Clinical Oncology, 2004
- Potential for Bias in Studies on Efficacy of Prophylactic Surgery for BRCA1 and BRCA2 MutationJNCI: Journal of the National Cancer Institute, 2003
- The Pathology of Familial Breast Cancer: Predictive Value of Immunohistochemical Markers Estrogen Receptor, Progesterone Receptor, HER-2, and p53 in Patients With Mutations in BRCA1 and BRCA2Journal of Clinical Oncology, 2002
- Efficacy of Bilateral Prophylactic Mastectomy in BRCA1 and BRCA2 Gene Mutation CarriersJNCI: Journal of the National Cancer Institute, 2001
- Breast Cancer after Prophylactic Bilateral Mastectomy in Women with aBRCA1orBRCA2MutationNew England Journal of Medicine, 2001
- Efficacy of Bilateral Prophylactic Mastectomy in Women with a Family History of Breast CancerNew England Journal of Medicine, 1999
- Recommendations for Follow-up Care of Individuals With an Inherited Predisposition to CancerJAMA, 1997
- Primary Breast Cancer After Prophylactic MastectomyAmerican Journal of Clinical Oncology, 1991
- Cancer of the breast after prophylactic subcutaneous mastectomyThe American Journal of Surgery, 1984
- Failure of subcutaneous mastectomy to prevent the development of breast cancerJournal of Surgical Oncology, 1984